
|Articles|April 14, 2017
- Vol 34 No 4
- Volume 34
- Issue 4
Taking the Pulse
Author(s)Richard M. Berlin, MD
Introduce yourself, shake hands, sit down. Always sit down. Then ask for permission...
Advertisement
Introduce yourself,
shake hands, sit down.
Always sit down.
Then ask for permission.
Press the wrist’s flesh
with the same pressure
you placed on your chest
when you swore your oath.
Count the rate.
Close your eyes.
Appreciate the rhythm,
each rise and fall,
crescendo, pause,
flutter and thrill,
the flow, the stream,
a body entered
through 2 fingertips
with enough nerve
and sense to reveal
the secrets deep
in your patient’s heart.
Articles in this issue
over 9 years ago
Introduction: Deep Dives and Intellectual Jujitsuover 9 years ago
Assisted Outpatient Treatment Enters the Mainstreamover 9 years ago
Across the (Psychiatric) Universeover 9 years ago
Bizarro WorldAdvertisement
Related to this article

Explore the urgent legal, ethical, and clinical challenges in emergency psychiatry, share cases and tips, and contribute to Psychiatric Times’ November series.

Alkermes launches a phase 2 trial of oral orexin-2 agonist ALKS 7290 to boost antidepressant response in major depressive disorder, assessing safety and symptom relief.

BCG vaccination curbs tau tangles in mice by boosting microglial cleanup, fueling hopes for human trials to reduce dementia risk.

GLP-1 weight-loss drugs may worsen eating disorders or mask symptoms; experts urge careful screening, specialist referral, and monitoring before, during, and after use.

Sabirnetug phase 2 Alzheimer trial misses cognitive endpoint despite lowering amyloid, prompting Acumen to halt development and open-label extension plans.

Psychedelic trials often exclude real-world comorbidities; clinicians must weigh blinding limits, dosing durability, support needs, safety risks, and uneven system readiness.
Advertisement
Advertisement
Trending on Psychiatric Times
1
October 2026 in Review: Updates on the Psychiatric Treatment Pipeline, FDA News
2
Presenting Our November 2026 Theme: Emergency Psychiatry
3
Assessing Interventions for Insomnia in Peri- and Postmenopausal Women
4
ALKS 7290 for Adjunctive Treatment for MDD Enters Phase 2 Study
5


